HealthCap Africa

HealthCap Africa is a pan-African, female-led venture firm based in Lagos with explicit focus on healthtech and fintech-adjacent health, deploying $250k-$1M cheques at pre-seed, seed, and Series A. The firm differentiates on sector specialty (healthcare and life sciences are the core mandate), African market depth, and a women-led leadership team that has built credibility across the continent’s health-tech ecosystem. For founders, HealthCap is best positioned as a category-focused early lead for African founders building digital health, telemedicine, AI clinical tools, or health IT software with mission-aligned commercial economics. The right founder profile is an African operator building a defensible health-tech platform with paid customers, a credible regulatory navigation plan, and ambitions to scale across multiple African markets. Founders running deep biotech, capital-intensive hospital networks, or non-African ventures without continental presence are a poor fit. Entry path is via the AVCA African venture network, an existing HealthCap portfolio CEO, or warm introductions from co-investing African seed funds (FirstCheck, EchoVC, Enza). In the pitch, lead with multi-country unit economics in local currency, regulatory pathway in target markets, named clinical or insurer partnerships, and a credible Series A or B plan that names likely international leads. Caveats: African follow-on capital depth at Series B and beyond is structurally limited, so founders should plan international leads (US, UK, DFI) early. The firm’s AI focus is real but selective, and AI claims will be evaluated commercially rather than on model novelty. Public deal disclosures are uneven, so request a recent deal sheet to confirm pacing, current vintage, and reserves policy during initial diligence. HealthCap’s mission orientation does not preclude commercial discipline; partners will probe unit economics and scalability rigorously.